Guanghao Liang

140

105

202120222023202417 100 139 66

Public access

3 articles

0 articles

available

not available

Based on funding mandates

Dali HanThe University of ChicagoVerified email at uchicago.edu
Meng Michelle XuTsinghua UniversityVerified email at tsinghua.edu.cn
Yi (Ethan) LiuPhD candidate tsinghua UniversityVerified email at mails.tsinghua.edu.cn
Jun LiuSchool of Life Sciences, Peking UniversityVerified email at pku.edu.cn
Cai Guang YangProfessor of Chemistry, Chinese Academy of SciencesVerified email at simm.ac.cn
Qiancheng YouUniversity of ChicagoVerified email at uchicago.edu
Chuan HeThe University of ChicagoVerified email at uchicago.edu

Guanghao Liang

Beijing Institute of Genomics

Verified email at mail3.sysu.edu.cn


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance Y Liu, G Liang, H Xu, W Dong, Z Dong, Z Qiu, Z Zhang, F Li, Y Huang, Y Li, ... Cell metabolism 33 (6), 1221-1233. e11, 2021	171	2021
The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth L Dong, C Chen, Y Zhang, P Guo, Z Wang, J Li, Y Liu, J Liu, R Chang, ... Cancer cell 39 (7), 945-957. e10, 2021	151	2021
Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy G Liang, L Wang, Q You, K Cahill, C Chen, W Zhang, N Fulton, W Stock, ... Advanced Science 10 (23), 2300445, 2023		2023
5hmC Gene Signature Predicts the Treatment Response to Azacitidine with High-Dose Cytarabine and Mitoxantrone in AML K Cahill, L Wang, G Liang, Q You, C Chen, W Zhang, N Fulton, W Stock, ... Blood 138, 1305, 2021		2021

The system can't perform the operation now. Try again later.

Articles 1–4

Citations per year